The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Clotrimazole Market Research Report 2025

Global Clotrimazole Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1409102

No of Pages : 88

Synopsis
Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad-spectrum antimycotic agent effective pathogenic dermophytes, yeasts, Candida, Trichophyton, etc.
The global Clotrimazole market was valued at US$ 5 million in 2023 and is anticipated to reach US$ 5 million by 2030, witnessing a CAGR of 1.2% during the forecast period 2024-2030.
Global Clotrimazole key players include Guangzhou Hanpu, Jiangsu Yunyang, Bayer, Erregierre, Wuhan DKY, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, with a share over 60%, followed by EU and India, both have a share over 30%.
In terms of product, Cream is the largest segment, with a share over 40%. And in terms of application, the largest application is Vaginitis, followed by Tinea of Feed and Hands, Tinea Corporis, etc.
This report aims to provide a comprehensive presentation of the global market for Clotrimazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clotrimazole.
Report Scope
The Clotrimazole market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clotrimazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clotrimazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Erregierre
F.I.S.
Amoli Organics
CordenPharma
Ciron Group
Halcyon Labs
INFA Group
Manus Aktteva
Guangzhou Hanpu
Jiangsu Yunyang
Wuhan DKY
Hubei Aoxiang
Jintan Zhongxing
Segment by Type
Suppository
Tablet
Cream
Others
Segment by Application
Vaginitis
Otomycosis
Paronychia
Tinea of Feed and Hands
Tinea Corporis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Clotrimazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Clotrimazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Clotrimazole Market Overview
1.1 Product Overview and Scope of Clotrimazole
1.2 Clotrimazole Segment by Type
1.2.1 Global Clotrimazole Market Value Comparison by Type (2024-2030)
1.2.2 Suppository
1.2.3 Tablet
1.2.4 Cream
1.2.5 Others
1.3 Clotrimazole Segment by Application
1.3.1 Global Clotrimazole Market Value by Application: (2024-2030)
1.3.2 Vaginitis
1.3.3 Otomycosis
1.3.4 Paronychia
1.3.5 Tinea of Feed and Hands
1.3.6 Tinea Corporis
1.3.7 Others
1.4 Global Clotrimazole Market Size Estimates and Forecasts
1.4.1 Global Clotrimazole Revenue 2019-2030
1.4.2 Global Clotrimazole Sales 2019-2030
1.4.3 Global Clotrimazole Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Clotrimazole Market Competition by Manufacturers
2.1 Global Clotrimazole Sales Market Share by Manufacturers (2019-2024)
2.2 Global Clotrimazole Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Clotrimazole Average Price by Manufacturers (2019-2024)
2.4 Global Clotrimazole Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Clotrimazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Clotrimazole, Product Type & Application
2.7 Clotrimazole Market Competitive Situation and Trends
2.7.1 Clotrimazole Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Clotrimazole Players Market Share by Revenue
2.7.3 Global Clotrimazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Clotrimazole Retrospective Market Scenario by Region
3.1 Global Clotrimazole Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Clotrimazole Global Clotrimazole Sales by Region: 2019-2030
3.2.1 Global Clotrimazole Sales by Region: 2019-2024
3.2.2 Global Clotrimazole Sales by Region: 2025-2030
3.3 Global Clotrimazole Global Clotrimazole Revenue by Region: 2019-2030
3.3.1 Global Clotrimazole Revenue by Region: 2019-2024
3.3.2 Global Clotrimazole Revenue by Region: 2025-2030
3.4 North America Clotrimazole Market Facts & Figures by Country
3.4.1 North America Clotrimazole Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Clotrimazole Sales by Country (2019-2030)
3.4.3 North America Clotrimazole Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Clotrimazole Market Facts & Figures by Country
3.5.1 Europe Clotrimazole Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Clotrimazole Sales by Country (2019-2030)
3.5.3 Europe Clotrimazole Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Clotrimazole Market Facts & Figures by Country
3.6.1 Asia Pacific Clotrimazole Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Clotrimazole Sales by Country (2019-2030)
3.6.3 Asia Pacific Clotrimazole Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Clotrimazole Market Facts & Figures by Country
3.7.1 Latin America Clotrimazole Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Clotrimazole Sales by Country (2019-2030)
3.7.3 Latin America Clotrimazole Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Clotrimazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Clotrimazole Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Clotrimazole Sales by Country (2019-2030)
3.8.3 Middle East and Africa Clotrimazole Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Clotrimazole Sales by Type (2019-2030)
4.1.1 Global Clotrimazole Sales by Type (2019-2024)
4.1.2 Global Clotrimazole Sales by Type (2025-2030)
4.1.3 Global Clotrimazole Sales Market Share by Type (2019-2030)
4.2 Global Clotrimazole Revenue by Type (2019-2030)
4.2.1 Global Clotrimazole Revenue by Type (2019-2024)
4.2.2 Global Clotrimazole Revenue by Type (2025-2030)
4.2.3 Global Clotrimazole Revenue Market Share by Type (2019-2030)
4.3 Global Clotrimazole Price by Type (2019-2030)
5 Segment by Application
5.1 Global Clotrimazole Sales by Application (2019-2030)
5.1.1 Global Clotrimazole Sales by Application (2019-2024)
5.1.2 Global Clotrimazole Sales by Application (2025-2030)
5.1.3 Global Clotrimazole Sales Market Share by Application (2019-2030)
5.2 Global Clotrimazole Revenue by Application (2019-2030)
5.2.1 Global Clotrimazole Revenue by Application (2019-2024)
5.2.2 Global Clotrimazole Revenue by Application (2025-2030)
5.2.3 Global Clotrimazole Revenue Market Share by Application (2019-2030)
5.3 Global Clotrimazole Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Clotrimazole Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Erregierre
6.2.1 Erregierre Corporation Information
6.2.2 Erregierre Description and Business Overview
6.2.3 Erregierre Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Erregierre Clotrimazole Product Portfolio
6.2.5 Erregierre Recent Developments/Updates
6.3 F.I.S.
6.3.1 F.I.S. Corporation Information
6.3.2 F.I.S. Description and Business Overview
6.3.3 F.I.S. Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.3.4 F.I.S. Clotrimazole Product Portfolio
6.3.5 F.I.S. Recent Developments/Updates
6.4 Amoli Organics
6.4.1 Amoli Organics Corporation Information
6.4.2 Amoli Organics Description and Business Overview
6.4.3 Amoli Organics Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amoli Organics Clotrimazole Product Portfolio
6.4.5 Amoli Organics Recent Developments/Updates
6.5 CordenPharma
6.5.1 CordenPharma Corporation Information
6.5.2 CordenPharma Description and Business Overview
6.5.3 CordenPharma Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CordenPharma Clotrimazole Product Portfolio
6.5.5 CordenPharma Recent Developments/Updates
6.6 Ciron Group
6.6.1 Ciron Group Corporation Information
6.6.2 Ciron Group Description and Business Overview
6.6.3 Ciron Group Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ciron Group Clotrimazole Product Portfolio
6.6.5 Ciron Group Recent Developments/Updates
6.7 Halcyon Labs
6.6.1 Halcyon Labs Corporation Information
6.6.2 Halcyon Labs Description and Business Overview
6.6.3 Halcyon Labs Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Halcyon Labs Clotrimazole Product Portfolio
6.7.5 Halcyon Labs Recent Developments/Updates
6.8 INFA Group
6.8.1 INFA Group Corporation Information
6.8.2 INFA Group Description and Business Overview
6.8.3 INFA Group Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.8.4 INFA Group Clotrimazole Product Portfolio
6.8.5 INFA Group Recent Developments/Updates
6.9 Manus Aktteva
6.9.1 Manus Aktteva Corporation Information
6.9.2 Manus Aktteva Description and Business Overview
6.9.3 Manus Aktteva Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Manus Aktteva Clotrimazole Product Portfolio
6.9.5 Manus Aktteva Recent Developments/Updates
6.10 Guangzhou Hanpu
6.10.1 Guangzhou Hanpu Corporation Information
6.10.2 Guangzhou Hanpu Description and Business Overview
6.10.3 Guangzhou Hanpu Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Guangzhou Hanpu Clotrimazole Product Portfolio
6.10.5 Guangzhou Hanpu Recent Developments/Updates
6.11 Jiangsu Yunyang
6.11.1 Jiangsu Yunyang Corporation Information
6.11.2 Jiangsu Yunyang Clotrimazole Description and Business Overview
6.11.3 Jiangsu Yunyang Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jiangsu Yunyang Clotrimazole Product Portfolio
6.11.5 Jiangsu Yunyang Recent Developments/Updates
6.12 Wuhan DKY
6.12.1 Wuhan DKY Corporation Information
6.12.2 Wuhan DKY Clotrimazole Description and Business Overview
6.12.3 Wuhan DKY Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Wuhan DKY Clotrimazole Product Portfolio
6.12.5 Wuhan DKY Recent Developments/Updates
6.13 Hubei Aoxiang
6.13.1 Hubei Aoxiang Corporation Information
6.13.2 Hubei Aoxiang Clotrimazole Description and Business Overview
6.13.3 Hubei Aoxiang Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hubei Aoxiang Clotrimazole Product Portfolio
6.13.5 Hubei Aoxiang Recent Developments/Updates
6.14 Jintan Zhongxing
6.14.1 Jintan Zhongxing Corporation Information
6.14.2 Jintan Zhongxing Clotrimazole Description and Business Overview
6.14.3 Jintan Zhongxing Clotrimazole Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jintan Zhongxing Clotrimazole Product Portfolio
6.14.5 Jintan Zhongxing Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Clotrimazole Industry Chain Analysis
7.2 Clotrimazole Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Clotrimazole Production Mode & Process
7.4 Clotrimazole Sales and Marketing
7.4.1 Clotrimazole Sales Channels
7.4.2 Clotrimazole Distributors
7.5 Clotrimazole Customers
8 Clotrimazole Market Dynamics
8.1 Clotrimazole Industry Trends
8.2 Clotrimazole Market Drivers
8.3 Clotrimazole Market Challenges
8.4 Clotrimazole Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’